Transparency Market Research (http://www.transparencymarketresearch.com) includes new market research report "Intra-Dialytic Hypotension Market" to its huge collection of research reports.
Albany, NY -- (SBWIRE) -- 11/20/2014 -- Most of the people who are suffering from end-stage renal disease undergo hemodialysis, and is often accompanied by recurrent and troubling side-effects, which are referred to as intra-dialytic hypotension (IDH). IDH has been estimated to affect around 15% to 55% of all patients undergoing hemodialysis. Some of the major symptoms of IDH include nausea, diaphoresis and cramps, to more precarious conditions that include angina pectoris, arrhythmias, seizures, unconsciousness and even cardiac arrests. IDH is mainly caused due to inefficient cardiovascular response to the reduced blood volume, which is bound to occur due to the removal of large volumes of water in a very short span. As a typical hemodialysis procedure involves the removal of an ultrafiltrate volume of water from the patient’s body, which is equal to or even greater than the entire blood plasma of the patient.
Early buyers will receive 10% customization on reports
The occurrence of IDH would increase further due to ageing population that exhibit greater comorbidities, such as cardiovascular problems and diabetes, thus making IDH a problem that requires extensive rethinking and innovation. Several drug developers and manufacturers are involved in extensive research and development and many of them have a considerable number of drugs in different stages of clinical trials in this field. Some of the important drugs that are in different stages of clinical trials that will soon be commercialized in the global market include, MTR107, Droxidopa, Mannitol, Northera and Norathiol among others.
Some of the major driving factors for the growth of this market include, high number of patients undergoing hemodialysis, aging population, rising demand for advanced therapeutics, high number of drugs in the pipeline and rising awareness and affordability of the people globally. At present, many people are undergoing hemodialysis due to kidney failure or end stage renal diseases, which in turn increase the chances of developing IDH, thus, will contribute towards the growth of this market in future. Also, aged individuals increasingly require hemodialysis, hence are more prone towards IDH, hence will add to this market’s growth in future. Comorbidities such as, diabetes and cardiovascular diseases also increase the chances of developing renal disorders, hence in turn will increase IDH occurrences, hence the demand for advanced therapeutics. Thus, rising awareness and demand along with high number of pipeline drugs that will soon be commercialized in the global market will augment the growth of this market in the near future.
Geographically, North America and Europe are expected to dominate the global intra-dialytic hypotension market. Some of the key factors that are expected to be responsible for their dominance in this market are high number of patients undergoing renal hemodialysis along with the presence of large geriatric population in these regions. Most of the companies that are involved in the research and development activities in this field and have a few drugs in the pipeline also belong to these regions. Thus, it is expected that these regions will largely dominate this market in future. However, Asia Pacific that constitutes some of the fastest emerging economies of the world along with increasing number of patients with renal diseases will help grow this market in this region in future.
Some of the major players having their drugs in different stages of clinical trials in this market include, Advanced Circulatory Systems, Inc., B. Braun Melsungen AG, Chelsea Therapeutics, Inc., Global Monitors, Inc., Medinox, Inc., Meditor Pharmaceuticals Ltd. and Wolfson Medical Center.
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Read More Reports on Medical Devices Market: http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html
About Transparency Market Research
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
Inquiry Before Buying @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3164
Latest Upcoming Reports: http://www.transparencymarketresearch.com/upcoming.htm
90 State Street,
Albany NY - 12207
Browse market research blog: